SKYE logo

Skye Bioscience (SKYE) Company Overview

Profile

Full Name:

Skye Bioscience, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

November 26, 2014

Indexes:

Not included

Description:

Skye Bioscience is a biotechnology company focused on developing cannabinoid-based therapies for various medical conditions, aiming to improve patient outcomes through innovative treatments.

Events Calendar

Earnings

Next earnings date:

May 8, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Sep 8, 2023

Analyst ratings

Recent major analysts updates

Feb 28, 25 William Blair
Outperform
Sep 30, 24 Scotiabank
Sector Outperform
Sep 20, 24 Piper Sandler
Overweight
Sep 20, 24 Cantor Fitzgerald
Overweight
Sep 10, 24 JMP Securities
Market Outperform
Sep 9, 24 Cantor Fitzgerald
Overweight
Sep 6, 24 Cantor Fitzgerald
Overweight
Aug 27, 24 Cantor Fitzgerald
Overweight
Jul 9, 24 Craig-Hallum
Buy
Jul 1, 24 Cantor Fitzgerald
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Skye Bioscience?
  • Does Skye Bioscience pay dividends?
  • What sector is Skye Bioscience in?
  • What industry is Skye Bioscience in?
  • What country is Skye Bioscience based in?
  • When did Skye Bioscience go public?
  • Is Skye Bioscience in the S&P 500?
  • Is Skye Bioscience in the NASDAQ 100?
  • Is Skye Bioscience in the Dow Jones?
  • When was Skye Bioscience's last earnings report?
  • When does Skye Bioscience report earnings?
  • Should I buy Skye Bioscience stock now?

What is the ticker symbol for Skye Bioscience?

The ticker symbol for Skye Bioscience is NASDAQ:SKYE

Does Skye Bioscience pay dividends?

No, Skye Bioscience does not pay dividends

What sector is Skye Bioscience in?

Skye Bioscience is in the Healthcare sector

What industry is Skye Bioscience in?

Skye Bioscience is in the Biotechnology industry

What country is Skye Bioscience based in?

Skye Bioscience is headquartered in United States

When did Skye Bioscience go public?

Skye Bioscience's initial public offering (IPO) was on November 26, 2014

Is Skye Bioscience in the S&P 500?

No, Skye Bioscience is not included in the S&P 500 index

Is Skye Bioscience in the NASDAQ 100?

No, Skye Bioscience is not included in the NASDAQ 100 index

Is Skye Bioscience in the Dow Jones?

No, Skye Bioscience is not included in the Dow Jones index

When was Skye Bioscience's last earnings report?

Skye Bioscience's most recent earnings report was on Nov 7, 2024

When does Skye Bioscience report earnings?

The next expected earnings date for Skye Bioscience is May 8, 2025

Should I buy Skye Bioscience stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions